Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market
Holding TENX?
Track your performance easily

Tenax Therapeutics (TENX) Financial Statements

523 Followers

Tenax Therapeutics Financial Overview

Tenax Therapeutics's market cap is currently ―. The company's EPS TTM is $-22.366; its P/E ratio is -0.16; Tenax Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 3.58M$ -4.03M$ -1.97M$ -1.10M$ -1.40M
EBITDA$ 3.58M$ -4.03M$ -1.97M$ -1.10M$ -1.40M
Net Income Common Stockholders$ 3.58M$ 3.80M$ -1.97M$ -1.11M$ -1.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 13.39M$ 14.41M
Total Assets$ 10.62M$ 14.46M$ 11.89M$ 14.05M$ 15.27M
Total Debt$ 278.80K$ 413.17K$ 174.47K$ 345.75K$ 513.91K
Net Debt$ 278.80K$ 413.17K$ 174.47K$ -13.05M$ -13.90M
Total Liabilities$ 1.74M$ 2.03M$ 602.21K$ 823.84K$ 993.86K
Stockholders Equity$ 8.88M$ 12.43M$ 11.29M$ 13.22M$ 14.28M
Cash Flow-
Free Cash Flow$ -10.63M$ 2.43M$ -2.08M$ -924.57K$ -1.73M
Operating Cash Flow$ -10.63M$ 2.43M$ -2.08M$ -922.97K$ -1.72M
Investing Cash Flow---$ 1.60K$ 1.24K
Financing Cash Flow$ -134.37K$ 7.92M$ -171.28K$ -99.91K$ 14.01M
Currency in USD

Tenax Therapeutics Earnings and Revenue History

Tenax Therapeutics Debt to Assets

Tenax Therapeutics Cash Flow

Tenax Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis